NCT03978091View on ClinicalTrials.gov

A Trial to Evaluate the Pharmacokinetics and Safety of AVYCAZ(R) in Combination With Aztreonam

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

July 9, 2019

Primary Completion Date

November 23, 2020

Study Completion Date

November 23, 2020

Conditions
Bacterial Infection
Interventions
DRUG

AZACTAM

A synthetic monobactam antibiotic originally isolated from Chromobacterium violaceum

DRUG

Ceftazidime-Avibactam

An antibacterial combination product containing ceftazidime and avibactam

Trial Locations (1)

27710-4000

Duke University School of Medicine - Duke Clinical Research Institute - Duke Clinical Research Unit, Durham

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT03978091 - A Trial to Evaluate the Pharmacokinetics and Safety of AVYCAZ(R) in Combination With Aztreonam | Biotech Hunter | Biotech Hunter